Adjunctive Semaglutide in Patients Undergoing Intragastric Balloon for Weight Loss: 12-Month Prospective Comparative Study - Poll - MDSpire

Adjunctive Semaglutide in Patients Undergoing Intragastric Balloon for Weight Loss: 12-Month Prospective Comparative Study

  • By

  • Khaled E. Barakat

  • Doaa K. Abuhasan

  • Mohamed F. Asal

  • Ahmed Adham R. Elsayed

  • Mohamed R. Mahmoud

  • Madeline Guy

  • Rama Safadi

  • Marc D. Basson

  • November 10, 2025

  • 0 min

Share

Original Source(s)

Adjunctive Semaglutide in Patients Undergoing Intragastric Balloon for Weight Loss: 12-Month Prospective Comparative Study

  • by Khaled E. Barakat, Doaa K. Abuhasan, Mohamed F. Asal, Ahmed Adham R. Elsayed, Mohamed R. Mahmoud, Madeline Guy, Rama Safadi, Marc D. Basson

  • November 10, 2025

Related Content

Correction: Link Between Zinc Deficiency and Healthcare Resource Use in Patients Receiving Metabolic and Bariatric Surgery: A Retrospective Cohort Analysis

Semaglutide versus placebo in individuals with poor weight loss after bariatric surgery: a double-blinded, randomized, placebo-controlled trial

A temporally Anchored Retrieval-Augmented Generation Framework for Metabolic and Bariatric Surgery Patient Education: An IFSO Artificial Intelligence Task Force Multinational Validation Study